Rheumatoid arthritis
Australian rheumatologists are rapid adopters of JAK inhibitors in RA
JAK inhibitors have been adopted with enthusiasm by Australian rheumatologists for the treatment of RA since they became available in 2015, according to figures from the OPAL (Optimising Patient outcomes in Australian rheumatoLogy) dataset.
About one in four patients with RA...
JAK inhibitors have been adopted with enthusiasm by Australian rheumatologists for the treatment of RA since they became available in...
